204 related articles for article (PubMed ID: 32648245)
21. SARS-CoV-2 and HIV: Epidemiology, Treatment, and Lessons Learned from HIV.
Castel AD; Wilbourn B; Magnus M; Greenberg AE
AIDS Rev; 2020; 22(3):133-142. PubMed ID: 33118529
[TBL] [Abstract][Full Text] [Related]
22. Response to Lim et al. re: "Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19".
Sengupta V; Sengupta S; Lazo A; Hicok KC; Moseley T
Stem Cells Dev; 2020 Jul; 29(14):879-881. PubMed ID: 32520639
[No Abstract] [Full Text] [Related]
23. Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19).
Chang FY; Chen HC; Chen PJ; Ho MS; Hsieh SL; Lin JC; Liu FT; Sytwu HK
J Biomed Sci; 2020 Jun; 27(1):72. PubMed ID: 32498686
[TBL] [Abstract][Full Text] [Related]
24. The Coronavirus Pandemic: What Does the Evidence Show?
Paudel S; Dangal G; Chalise A; Bhandari TR; Dangal O
J Nepal Health Res Counc; 2020 Apr; 18(1):1-9. PubMed ID: 32335585
[TBL] [Abstract][Full Text] [Related]
25. Re: "Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19" by Sengupta et al.
Lim SK; Giebel B; Weiss DJ; Witwer KW; Rohde E
Stem Cells Dev; 2020 Jul; 29(14):877-878. PubMed ID: 32520641
[No Abstract] [Full Text] [Related]
26. Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) infection during late pregnancy: a report of 18 patients from Wuhan, China.
Zhang L; Dong L; Ming L; Wei M; Li J; Hu R; Yang J
BMC Pregnancy Childbirth; 2020 Jul; 20(1):394. PubMed ID: 32641013
[TBL] [Abstract][Full Text] [Related]
27. COVID-19: The first documented coronavirus pandemic in history.
Liu YC; Kuo RL; Shih SR
Biomed J; 2020 Aug; 43(4):328-333. PubMed ID: 32387617
[TBL] [Abstract][Full Text] [Related]
28. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges.
Lai CC; Shih TP; Ko WC; Tang HJ; Hsueh PR
Int J Antimicrob Agents; 2020 Mar; 55(3):105924. PubMed ID: 32081636
[TBL] [Abstract][Full Text] [Related]
29. The SARS-CoV-2 Coronavirus and the COVID-19 Outbreak.
Lauxmann MA; Santucci NE; Autrán-Gómez AM
Int Braz J Urol; 2020 Jul; 46(suppl.1):6-18. PubMed ID: 32549071
[TBL] [Abstract][Full Text] [Related]
30. Geographical tracking and mapping of coronavirus disease COVID-19/severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic and associated events around the world: how 21st century GIS technologies are supporting the global fight against outbreaks and epidemics.
Kamel Boulos MN; Geraghty EM
Int J Health Geogr; 2020 Mar; 19(1):8. PubMed ID: 32160889
[TBL] [Abstract][Full Text] [Related]
31. Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients.
Al-Khawaga S; Abdelalim EM
Stem Cell Res Ther; 2020 Oct; 11(1):437. PubMed ID: 33059757
[TBL] [Abstract][Full Text] [Related]
32. Optimal Management of Acute Lymphoblastic Leukemia (ALL) in Adult Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic.
Alhuraiji A; Eldadah S; Alfraih F; Pandita R; Absi A; Hanbali A; Aljurf M; El Fakih R
Gulf J Oncolog; 2020 May; 1(33):7-18. PubMed ID: 32476644
[TBL] [Abstract][Full Text] [Related]
33. Potential therapeutic application of mesenchymal stem cell-derived exosomes in SARS-CoV-2 pneumonia.
Akbari A; Rezaie J
Stem Cell Res Ther; 2020 Aug; 11(1):356. PubMed ID: 32795359
[TBL] [Abstract][Full Text] [Related]
34. Mesenchymal Stromal Cell Secretome for Severe COVID-19 Infections: Premises for the Therapeutic Use.
Bari E; Ferrarotti I; Saracino L; Perteghella S; Torre ML; Corsico AG
Cells; 2020 Apr; 9(4):. PubMed ID: 32283815
[TBL] [Abstract][Full Text] [Related]
35. A More Excellent Way: Recovering Mystery in COVID Care.
Genig JD
J Relig Health; 2020 Oct; 59(5):2302-2307. PubMed ID: 32474836
[TBL] [Abstract][Full Text] [Related]
36. Mesenchymal Stem Cell-Based Therapy for COVID-19: Possibility and Potential.
Xiong J; Bao L; Qi H; Feng Z; Shi Y
Curr Stem Cell Res Ther; 2021; 16(2):105-108. PubMed ID: 32479246
[TBL] [Abstract][Full Text] [Related]
37. COVID-19 and its Therapeutics: Special Emphasis on Mesenchymal Stem Cells Based Therapy.
Verma YK; Verma R; Tyagi N; Behl A; Kumar S; Gangenahalli GU
Stem Cell Rev Rep; 2021 Feb; 17(1):113-131. PubMed ID: 32920752
[TBL] [Abstract][Full Text] [Related]
38. Fostering mesenchymal stem cell therapy to halt cytokine storm in COVID-19.
Jeyaraman M; John A; Koshy S; Ranjan R; Anudeep TC; Jain R; Swati K; Jha NK; Sharma A; Kesari KK; Prakash A; Nand P; Jha SK; Reddy PH
Biochim Biophys Acta Mol Basis Dis; 2021 Feb; 1867(2):166014. PubMed ID: 33232817
[TBL] [Abstract][Full Text] [Related]
39. Stem cell therapy for COVID-19: Possibilities and challenges.
Choudhery MS; Harris DT
Cell Biol Int; 2020 Nov; 44(11):2182-2191. PubMed ID: 32767687
[TBL] [Abstract][Full Text] [Related]
40. Stem Cells Secretome from Oral Tissue Could Represent a Promising Therapeutic Approach in COVID-19-Disease?
Diomede F; Marconi GD; Fonticoli L; Pizzicannella J; Trubiani O
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
